{"pmid":32236562,"title":"Treating COVID-19 with Chloroquine.","text":["Treating COVID-19 with Chloroquine.","J Mol Cell Biol","Huang, Mingxing","Tang, Tiantian","Pang, Pengfei","Li, Man","Ma, Ruolan","Lu, Jiahui","Shu, Jingxian","You, Yingying","Chen, Binghui","Liang, Jiabi","Hong, Zhongsi","Chen, Huili","Kong, Ling","Qin, Dajiang","Pei, Duanqing","Xia, Jinyu","Jiang, Shanping","Shan, Hong","32236562"],"journal":"J Mol Cell Biol","authors":["Huang, Mingxing","Tang, Tiantian","Pang, Pengfei","Li, Man","Ma, Ruolan","Lu, Jiahui","Shu, Jingxian","You, Yingying","Chen, Binghui","Liang, Jiabi","Hong, Zhongsi","Chen, Huili","Kong, Ling","Qin, Dajiang","Pei, Duanqing","Xia, Jinyu","Jiang, Shanping","Shan, Hong"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32236562","week":"202014|Mar 30 - Apr 05","doi":"10.1093/jmcb/mjaa014","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662996001834663936,"score":7.6048946,"similar":[{"pmid":32237918,"title":"Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.","text":["Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.","Clin Toxicol (Phila)","Megarbane, Bruno","32237918"],"journal":"Clin Toxicol (Phila)","authors":["Megarbane, Bruno"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32237918","week":"202014|Mar 30 - Apr 05","doi":"10.1080/15563650.2020.1748194","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662996001783283712,"score":56.328655},{"pmid":32147496,"title":"Of chloroquine and COVID-19.","text":["Of chloroquine and COVID-19.","Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.","Antiviral Res","Touret, Franck","de Lamballerie, Xavier","32147496"],"abstract":["Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research."],"journal":"Antiviral Res","authors":["Touret, Franck","de Lamballerie, Xavier"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32147496","week":"202011|Mar 09 - Mar 15","doi":"10.1016/j.antiviral.2020.104762","keywords":["2019-nCoV","Antiviral","COVID-19","Chloroquine","SARS-CoV-2"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662334543897559040,"score":41.612267}]}